Advertisement
Singapore markets closed

  • Straits Times Index

    3,293.13
    +20.41 (+0.62%)
     

  • S&P 500

    5,070.55
    +59.95 (+1.20%)
     

  • Dow

    38,503.69
    +263.71 (+0.69%)
     

  • Nasdaq

    15,696.64
    +245.33 (+1.59%)
     

  • Bitcoin USD

    66,361.44
    +207.08 (+0.31%)
     

  • CMC Crypto 200

    1,432.34
    +8.24 (+0.58%)
     

  • FTSE 100

    8,090.29
    +45.48 (+0.57%)
     

  • Gold

    2,331.30
    -10.80 (-0.46%)
     

  • Crude Oil

    83.01
    -0.35 (-0.42%)
     

  • 10-Yr Bond

    4.5980
    -0.0250 (-0.54%)
     

  • Nikkei

    38,460.08
    +907.92 (+2.42%)
     

  • Hang Seng

    17,201.27
    +372.34 (+2.21%)
     

  • FTSE Bursa Malaysia

    1,571.48
    +9.84 (+0.63%)
     

  • Jakarta Composite Index

    7,174.53
    +63.72 (+0.90%)
     

  • PSE Index

    6,572.75
    +65.95 (+1.01%)
     

Strength Seen in Cardlytics (CDLX): Can Its 12.1% Jump Turn into More Strength?

Zacks Equity Research
·2-min read

Cardlytics (CDLX) shares ended the last trading session 12.1% higher at $7.15. The jump came on an impressive volume with a higher-than-average number of shares changing hands in the session. This compares to the stock's 9.4% gain over the past four weeks.

The stock is benefiting from the company’s growing customer base of advertisers and acquisitions of Dosh and Bridg.

This company is expected to post quarterly loss of $0.53 per share in its upcoming report, which represents a year-over-year change of -253.3%. Revenues are expected to be $84.33 million, down 6.4% from the year-ago quarter.

Earnings and revenue growth expectations certainly give a good sense of the potential strength in a stock, but empirical research shows that trends in earnings estimate revisions are strongly correlated with near-term stock price movements.

ADVERTISEMENT

For Cardlytics, the consensus EPS estimate for the quarter has remained unchanged over the last 30 days. And a stock's price usually doesn't keep moving higher in the absence of any trend in earnings estimate revisions. So, make sure to keep an eye on CDLX going forward to see if this recent jump can turn into more strength down the road.

The stock currently carries a Zacks Rank #3 (Hold). You can see the complete list of today's Zacks Rank #1 (Strong Buy) stocks here >>>>

Cardlytics belongs to the Zacks Technology Services industry. Another stock from the same industry, Distribution Solutions Group (DSGR), closed the last trading session 1.2% lower at $40.67. Over the past month, DSGR has returned 12.5%.

Distribution Solutions' consensus EPS estimate for the upcoming report has remained unchanged over the past month at $0.45. Compared to the company's year-ago EPS, this represents a change of -13.5%. Distribution Solutions currently boasts a Zacks Rank of #3 (Hold).

Want the latest recommendations from Zacks Investment Research? Today, you can download 7 Best Stocks for the Next 30 Days. Click to get this free report

Cardlytics, Inc. (CDLX) : Free Stock Analysis Report

Distribution Solutions Group, Inc. (DSGR) : Free Stock Analysis Report

To read this article on Zacks.com click here.

Zacks Investment Research